Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| Xenia Kovacs joins growing ECG Core Lab provider, HeartcoR Solutions, as associate director of clinical project management | ||
| By: PR Newswire Association LLC. - 08 Aug 2022 | Back to overview list |
|
|
Kovacs will lead clinical project management team that is currently handling multiple studies globally while overseeing recruitment, training, and performance of project management staff SCHAUMBURG, Ill., Aug. 8, 2022 /PRNewswire-PRWeb/ -- HeartcoR Solutions, a leading ECG Core Lab provider that delivers 'round the clock clinical research for cardiac safety studies to pharmaceutical, medical device, and CROs worldwide, announced today that Xenia Kovacs has joined the organization as associate director of project management. Kovacs has more than 25 years of experience managing scientific clinical studies at premier healthcare and life sciences organizations. In her new role, she will provide leadership to HeartcoR's project teams, while overseeing project management recruitment to accommodate an increase in the number and size of clinical trials HeartcoR is managing. "Xenia's demonstrated success managing clinical trial teams and programs will be critical as we continue to expand our operations and extend the reach of our services," said John Icardi, president and COO, HeartcoR Solutions. "We are thrilled to add Xenia's expertise to our dedicated team of clinical project managers who work tirelessly to support the needs of study sponsors and participants." Prior to joining HeartcoR, Kovacs served in senior clinical project management roles for Abbott Molecular, Abbott/AbbVie, and Pfizer. She earned a Bachelor of Science degree from Nagy Lajos College in Pecs, Hungary, and completed legal training at the University of Pecs School of Law. Kovacs has co-authored several scientific journal articles, and has been recognized for scientific excellence from leading neuroscience and pharmaceutical organizations. "The HeartcoR team has demonstrated a commitment to thoughtful collaboration and using the most advanced technology to ensure the safe, efficient, accurate, and timely completion of early- and late-stage ECG safety trials, and I am excited to be part of the company's future growth," said Kovacs. To learn more about HeartcoR Solutions, visit http://www.HeartcoRSolutions.com. ### About HeartcoR Solutions Media Contact Barbara Tabor, HeartcoR Solutions, 651-230-9192, barbara@taborpr.com
SOURCE HeartcoR Solutions 
|
||
|
|
||
 | Back to overview list | |